EU’s failure to give AZ Covid jab is ‘to blame for soaring cases and lockdowns’

EUROPE’S failure to give the AstraZeneca Covid jab to elderly people could be why the continent is seeing a new wave, a vaccine boss has said.

Several countries are facing fresh lockdowns because infections are so high and some hospitals are coming under strain.


Pascal Soriot, the chief executive officer of AstraZeneca, has said the UK is not seeing many hospitalisations compared with Europe. He suggested this was because it used the AZ Covid jab in the elderlyCredit: Getty
Hospital admissions per population (million) across Europe


Hospital admissions per population (million) across EuropeCredit: Our World in Data

New restrictions and threats of using mandatory vaccines in Austria and Germany has caused outrage and protests across the region.

But the UK, while seeing high Covid case numbers, has not recorded drastic hospital admissions or deaths for months.

Vaccines have largely severed the link between infections and severe illness.

Pascal Soriot, the chief executive officer of AstraZeneca, has suggested this may be because the UK used the company’s Covid jab, created by Oxford University, to protect the elderly.

He told the BBC Radio 4 Today programme: “It’s really interesting when you look at the UK – there was a big peak of infections, but not so many hospitalisations relative to Europe. 

“In the UK, this vaccine was used to vaccinate older people. Whereas in Europe, people initially thought the vaccine didn’t work in elderly people.”

Asked if this was a mistake on Europe’s part that had led to the current wave of infections, Mr Soriot said: “I’m not saying there was any mistake by anybody. 

“But there is still a lot of data that needs to be made available that we don’t have.”

The EU shunned the AZ jab in the early days of the vaccine rollouts while the UK raced to get doses into arms from December 2020.

A number of countries initially refused to use it in people over the age of 65, concerned that there was not enough data that it was effective.

It wasn’t until March – three months after the UK – that France and Germany eventually approved the jab for elders.

Then came the investigations into blood clots caused by the jab, which led to a series of European countries pausing their rollouts in a domino effect.

The move baffled scientists, with the World Health Organization urging nations to keep using the jab until there was more concrete evidence. 

After a “plausible link” was found, most European countries altered their guidance so that only older people were advised to get the jab.

But Denmark completely halted its use altogether.

European countries have mostly focused on using Pfizer/BioNTech vaccines, with a mix of Johnson & Johnson, China’s Sinopharm vaccine and Russia’s Sputnik V. 

In the UK, first and second doses of AZ and Pfizer have almost been equally split. Booster shots are almost entirely Pfizer.

Mr Soriot claimed the AstraZeneca vaccine produced a greater immune response than other Covid vaccines due to a surge in T cells.

T cells are a part of the immune system that are thought to give the longest protection against bugs – potentially years – but are not as easy to test for as antibodies.

Asked if the AstraZeneca vaccine was why there had been fewer hospitalisations in the UK, Mr Soriot said: “What I am saying is that T cells do matter and in particular it relates to the durability of the response, especially in older people. 

“And this vaccine has been shown to stimulate T cells to a higher degree in older people. 

“And so  we haven’t seen many hospitalisations in the UK – a lot of infections for sure, everyone’s talking about those.

“But what matters is are you severely ill or not? Are you hospitalised or not? And we haven’t seen so many of these hospitalisations in the UK.”

Mr Soriot explained: “The T cell response takes a little longer to come in, but it’s actually more durable. It lasts longer.

“Everybody is focused on antibodies, but you see those decline over time. 

“What remains, and is very important, is this T cell response, and as soon as the virus attacks you, they wake up and come to the rescue and defend you. 

“So you may be infected but they come to the rescue and you don’t get hospitalised.”

Vaccine types used in Europe. The UK has been almost equally split for the AstraZeneca and Pfizer jabs


Vaccine types used in Europe. The UK has been almost equally split for the AstraZeneca and Pfizer jabsCredit: Statista
There is a risk of a new Covid variant in Europe, EU chief says

We pay for your stories!

Do you have a story for The Sun news desk?

For all the latest Covid-19 News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TheDailyCheck is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected] The content will be deleted within 24 hours.